EP2632949 - CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.07.2018 Database last updated on 30.10.2024 | |
Former | The patent has been granted Status updated on 11.08.2017 | ||
Former | Grant of patent is intended Status updated on 04.08.2017 | ||
Former | Examination is in progress Status updated on 19.07.2017 | ||
Former | Grant of patent is intended Status updated on 07.03.2017 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states National Research Council of Canada 1200 Montreal Road Ottawa, Ontario K1A 0R6 / CA | [2013/36] | Inventor(s) | 01 /
HUSSACK, Greg 211 Ivy Crescent, Unit 5 Ottawa Ontario K1M 1X9 / CA | 02 /
ARBABI-GHAHROUDI, Mehdi 2242 Des Grands Champs Ottawa Ontario K1W 1K1 / CA | 03 /
MACKENZIE, Roger 2195 Hamelin Crescent Ottawa Ontario K1J 6K9 / CA | 04 /
TANHA, Jamshid 2162 Valin Street Orleans Ontario K4A 4T2 / CA | [2013/36] | Representative(s) | Fleuchaus, Andrea, et al Fleuchaus & Gallo Partnerschaft mbB Patent- und Rechsanwälte Steinerstraße 15/Haus A 81369 München / DE | [N/P] |
Former [2017/37] | Fleuchaus, Andrea, et al Fleuchaus & Gallo Partnerschaft mbB Patent- und Rechtsanwälte Steinerstrasse 15/A 81369 München / DE | ||
Former [2013/36] | Fleuchaus, Andrea, et al Fleuchaus & Gallo Partnerschaft Patent- und Rechtsanwälte Steinerstrasse 15/A 81369 München / DE | Application number, filing date | 11835397.8 | 25.10.2011 | [2017/37] | WO2011CA01201 | Priority number, date | US20100406254P | 25.10.2010 Original published format: US 406254 P | [2013/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012055030 | Date: | 03.05.2012 | Language: | EN | [2012/18] | Type: | A1 Application with search report | No.: | EP2632949 | Date: | 04.09.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.05.2012 takes the place of the publication of the European patent application. | [2013/36] | Type: | B1 Patent specification | No.: | EP2632949 | Date: | 13.09.2017 | Language: | EN | [2017/37] | Search report(s) | International search report - published on: | CA | 03.05.2012 | (Supplementary) European search report - dispatched on: | EP | 22.06.2015 | Classification | IPC: | C07K16/12, A61K39/395, G01N33/569 | [2017/11] | CPC: |
C07K16/1282 (EP,US);
A61P31/04 (EP);
G01N33/56911 (EP,US);
C07K2317/22 (EP,US);
C07K2317/35 (EP,US);
C07K2317/569 (EP,US);
C07K2317/76 (EP,US);
C07K2317/92 (EP,US);
C07K2317/94 (EP,US);
G01N2333/33 (EP,US)
(-)
|
Former IPC [2013/36] | C07K16/12, A61K39/395, A61K47/48, A61P31/04, C07K14/33, C07K17/00, C12N15/13, G01N33/53 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/36] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | CLOSTRIDIUM-DIFFICILE-SPEZIFISCHE ANTIKÖRPER UND VERWENDUNGEN DAVON | [2013/36] | English: | CLOSTRIDIUM DIFFICILE-SPECIFIC ANTIBODIES AND USES THEREOF | [2013/36] | French: | ANTICORPS SPÉCIFIQUES DE CLOSTRIDIUM DIFFICILE ET LEURS APPLICATIONS | [2013/36] | Entry into regional phase | 27.05.2013 | National basic fee paid | 27.05.2013 | Search fee paid | 27.05.2013 | Designation fee(s) paid | 27.05.2013 | Examination fee paid | Examination procedure | 27.05.2013 | Examination requested [2013/36] | 11.01.2016 | Amendment by applicant (claims and/or description) | 20.06.2016 | Despatch of a communication from the examining division (Time limit: M04) | 24.10.2016 | Reply to a communication from the examining division | 08.03.2017 | Communication of intention to grant the patent | 11.07.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 11.07.2017 | Fee for grant paid | 11.07.2017 | Fee for publishing/printing paid | 04.08.2017 | Information about intention to grant a patent | 04.08.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 20.06.2016 | Opposition(s) | 14.06.2018 | No opposition filed within time limit [2018/34] | Fees paid | Renewal fee | 29.10.2013 | Renewal fee patent year 03 | 23.10.2014 | Renewal fee patent year 04 | 27.10.2015 | Renewal fee patent year 05 | 25.10.2016 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 25.10.2011 | AL | 13.09.2017 | AT | 13.09.2017 | CY | 13.09.2017 | CZ | 13.09.2017 | DK | 13.09.2017 | EE | 13.09.2017 | ES | 13.09.2017 | FI | 13.09.2017 | HR | 13.09.2017 | IT | 13.09.2017 | LT | 13.09.2017 | LV | 13.09.2017 | MC | 13.09.2017 | MK | 13.09.2017 | NL | 13.09.2017 | PL | 13.09.2017 | PT | 13.09.2017 | RO | 13.09.2017 | RS | 13.09.2017 | SE | 13.09.2017 | SI | 13.09.2017 | SK | 13.09.2017 | SM | 13.09.2017 | TR | 13.09.2017 | IE | 25.10.2017 | LU | 25.10.2017 | MT | 25.10.2017 | BE | 31.10.2017 | CH | 31.10.2017 | LI | 31.10.2017 | BG | 13.12.2017 | NO | 13.12.2017 | GR | 14.12.2017 | IS | 13.01.2018 | [2020/34] |
Former [2020/27] | HU | 25.10.2011 | |
AT | 13.09.2017 | ||
CY | 13.09.2017 | ||
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
ES | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
MK | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
PT | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
TR | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2020/16] | HU | 25.10.2011 | |
AT | 13.09.2017 | ||
CY | 13.09.2017 | ||
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
ES | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
MK | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
TR | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2019/51] | HU | 25.10.2011 | |
AT | 13.09.2017 | ||
CY | 13.09.2017 | ||
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
ES | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
MK | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2019/46] | HU | 25.10.2011 | |
AT | 13.09.2017 | ||
CY | 13.09.2017 | ||
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
ES | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2019/35] | HU | 25.10.2011 | |
AT | 13.09.2017 | ||
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
ES | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2019/31] | HU | 25.10.2011 | |
AT | 13.09.2017 | ||
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/52] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SI | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/45] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
IE | 25.10.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/43] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
LU | 25.10.2017 | ||
MT | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/36] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
LU | 25.10.2017 | ||
BE | 31.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/35] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
LU | 25.10.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/33] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
DK | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
MC | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
CH | 31.10.2017 | ||
LI | 31.10.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/24] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
IT | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
SM | 13.09.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/23] | AT | 13.09.2017 | |
CZ | 13.09.2017 | ||
EE | 13.09.2017 | ||
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
NL | 13.09.2017 | ||
PL | 13.09.2017 | ||
RO | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
SK | 13.09.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
IS | 13.01.2018 | ||
Former [2018/21] | CZ | 13.09.2017 | |
FI | 13.09.2017 | ||
HR | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
NL | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
Former [2018/15] | FI | 13.09.2017 | |
HR | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
NL | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
Former [2018/12] | FI | 13.09.2017 | |
HR | 13.09.2017 | ||
LT | 13.09.2017 | ||
LV | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
Former [2018/11] | FI | 13.09.2017 | |
HR | 13.09.2017 | ||
LT | 13.09.2017 | ||
RS | 13.09.2017 | ||
SE | 13.09.2017 | ||
BG | 13.12.2017 | ||
NO | 13.12.2017 | ||
GR | 14.12.2017 | ||
Former [2018/09] | FI | 13.09.2017 | |
LT | 13.09.2017 | ||
SE | 13.09.2017 | ||
NO | 13.12.2017 | ||
Former [2018/08] | FI | 13.09.2017 | |
LT | 13.09.2017 | ||
NO | 13.12.2017 | ||
Former [2018/07] | LT | 13.09.2017 | |
NO | 13.12.2017 | Documents cited: | Search | [YA]WO2006099747 (CA NAT RESEARCH COUNCIL [CA], et al) [Y] 4-17 * page 1, line 10 - page 2, line 29 * [A] 1-3; | [YA] - BABCOCK GREGORY J ET AL, "Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20061101), vol. 74, no. 11, doi:10.1128/IAI.00982-06, ISSN 0019-9567, pages 6339 - 6347, XP009109025 [Y] 4-17 * abstract * * RESULTS: 'Isolation of human monoclonal antibodies directed against Clostridium difficile toxins A and B', 'Antitoxin HuMAbs protect hamsters from mortality associated with C. difficile disease' * * DISCUSSION * [A] 1-3 DOI: http://dx.doi.org/10.1128/IAI.00982-06 | International search | [A] - HUSSACK G. ET AL., "Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives", TOXINS, (2010), vol. 2, no. 5, pages 998 - 1018, XP002692188 DOI: http://dx.doi.org/10.3390/toxins2050998 | [A] - BABCOCK G.J. ET AL., "Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters", INFECTION AND IMMUNITY, (200611), vol. 74, no. 11, pages 6339 - 6347, XP009109025 DOI: http://dx.doi.org/10.1128/IAI.00982-06 | [XP] - HUSSACK G. ET AL., "Neutralization of Clostridium difficile toxin A with single- domain antibodies targeting the cell receptor binding domain", JOURNAL OF BIOLOGICAL CHEMISTRY, (20110107), vol. 286, no. 11, pages 8961 - 8976, XP002692187 DOI: http://dx.doi.org/10.1074/jbc.M110.198754 | Examination | - GREG HUSSACK AND JAMSHID TANHA, "Toxin-Specific Antibodies for the Treatment of Clostridium difficile: Current Status and Future Perspectives", TOXINS, MOLECULAR DIVERSITY PRESERVATION INTERNATIONAL (MDPI) AG, CH, vol. 2, no. 5, doi:10.3390/TOXINS2050998, ISSN 2072-6651, (20100501), pages 998 - 1018, (20100507), XP002686777 DOI: http://dx.doi.org/10.3390/toxins2050998 | by applicant | US6180370 | US5693761 | US6054297 | US5859205 | EP0626390 | US5869619 | US5766886 | US5821123 | EP0519596 | WO9504069 | WO2004076670 | WO03046560 | - ANDERSON, G.P.; LIU, J.L.; HALE, M.L.; BERNSTEIN, R.D.; MOORE, M.; SWAIN, M.D.; GOLDMAN, E.R., ANAL. CHEM., (2008), vol. 80, pages 9604 - 9611 | - ARBABI-GHAHROUDI, M.; MACKENZIE, R.; TANHA, J., METHODS MOL. BIOL., (2009), vol. 525, pages 187 - 216 | - ARBABI-GHAHROUDI, M.; MACKENZIE, R.; TANHA, J., METHODS MOL. BIOL., (2010), vol. 634, pages 309 - 330 | - ARBABI-GHAHROUDI, M.; TO, R.; GAUDETTE, N.; HIRAMA, T.; DING, W.; MACKENZIE, R.; TANHA, J., PROTEIN ENG. DES. SEL., (2009), vol. 22, pages 59 - 66 | - BABCOCK, G.J.; BROERING, T.J.; HERNANDEZ, H.J.; MANDELL, R.B.; DONAHUE, K.; BOATRIGHT, N.; STACK, A.M.; LOWY, I.; GRAZIANO, R.; MO, INFECT. IMMUN., (2006), vol. 74, pages 6339 - 6347 | - BELL, A.; WANG, Z.J.; ARBABI-GHAHROUDI, M.; CHANG, T.A.; DUROCHER, Y.; TROJAHN, U.; BAARDSNES, J.; JARAMILLO, M.L.; LI, S.; BARAL,, CANCER LETT., (2010), vol. 289, pages 81 - 90 | - CHOTHIA, C.; LESK, A.M., J. MOL. BIOL., (1987), vol. 196, pages 901 - 917 | - CORTHIER, G.; MULLER, M.C.; WILKINS, T.D.; LYERLY, D.; L'HARIDON, R., INFECT. IMMUN., (1991), vol. 59, pages 1192 - 1195 | - DE GENST, E.; SILENCE, K.; DECANNIERE, K.; CONRATH, K.; LORIS, R.; KINNE, J.; MUYLDERMANS, S.; WYNS, L., PROC. NATL. ACAD. SCI. U.S.A., (2006), vol. 103, pages 4586 - 4591 | - DE KRUIF, J.; LOGTENBERG, T., J. BIOL. CHEM., (1996), vol. 271, pages 7630 - 7634 | - DOYLE, P.J.; ARBABI-GHAHROUDI, M.; GAUDETTE, N.; FURZER, G.; SAVARD, M.E.; GLEDDIE, S.; MCLEAN, M.D.; MACKENZIE, C.R.; HALL, J.C., MOL. IMMUNOL., (2008), vol. 45, pages 3703 - 3713 | - EISENBERG, D.; SCHWARZ, E.; KOMAROMY, M.; WALL, R., J. MOL. BIOL., (1984), vol. 179, pages 125 - 142 | - FENNER, L.; WIDMER, A.F.; GOY, G.; RUDIN, S.; FREI, R., J. CLIN. MICROBIOL., (2008), vol. 46, pages 328 - 330 | - FLORIN, I.; THELESTAM, M., BIOCHIM. BIOPHYS. ACTA, (1983), vol. 763, pages 383 - 392 | - GARDINER, D.F.; ROSENBERG, T.; ZAHARATOS, J.; FRANCO, D.; HO, D.D., VACCINE, (2009), vol. 27, pages 3598 - 3604 | - GIANNASCA, P.J.; ZHANG, Z.X.; LEI, W.D.; BODEN, J.A.; GIEL, M.A.; MONATH, T.P.; THOMAS, W.D. JR., INFECT. IMMUN., (1999), vol. 67, pages 527 - 538 | - GOLDMAN, E.R.; ANDERSON, G.P.; CONWAY, J.; SHERWOOD, L.J.; FECH, M.; VO, B.; LIU, J.L.; HAYHURST, A., ANAL. CHEM., (2008), vol. 80, pages 8583 - 8591 | - GOLDMAN, E.R.; ANDERSON, G.P.; LIU, J.L.; DELEHANTY, J.B.; SHERWOOD, L.J.; OSBORN, L.E.; CUMMINS, L.B.; HAYHURST, A., ANAL. CHEM., (2006), vol. 78, pages 8245 - 8255 | - GRECO, A.; HO, J.G.; LIN, S.J.; PALCIC, M.M.; RUPNIK, M.; NG, K.K., NAT. STRUCT. MOL. BIOL., (2006), vol. 13, pages 460 - 461 | - HAGIHARA, Y.; MINE, S.; UEGAKI, K., J. BIOL. CHEM., (2007), vol. 282, pages 36489 - 36495 | - HAMERS-CASTERMAN, C.; ATARHOUCH, T.; MUYLDERMANS, S.; ROBINSON, G.; HAMERS, C.; SONGA, E.B.; BENDAHMAN, N.; HAMERS, R., NATURE, (1993), vol. 363, pages 446 - 448 | - HASSOUN, A.; IBRAHIM, F., AM. J. GERIATR. PHARMACOTHER., (2007), vol. 5, pages 48 - 51 | - HO, S.N.; HUNT, H.D.; HORTON, R.M.; PULLEN, J.K.; PEASE, L.R., GENE, (1989), vol. 77, pages 51 - 59 | - HMILA, I.; ABDALLAH, R.B.A.; SAERENS, D.; BENLASFAR, Z.; CONRATH, K.; AYEB, M.E.; MUYLDERMANS, S.; BOUHAOUALA-ZAHAR, B., MOL. IMMUNOL., (2008), vol. 45, pages 3847 - 3856 | - HUSSACK, G.; LUO, Y.; VELDHUIS, L.; HALL, J.C.; TANHA, J.; MACKENZIE, R., SENSORS, (2009), vol. 9, pages 5351 - 5367 | - IQBAL, U.; TROJAHN, U.; ALBAGHDADI, H.; ZHANG, J.; O'CONNOR, M.; STANIMIROVIC, D.; TOMANEK, B.; SUTHERLAND, G.; ABULROB, A., BR. J. PHARMACOL., (2010), vol. 160, pages 1016 - 1028 | - JANK, T.; AKTORIES, K., TRENDS MICROBIOL., (2008), vol. 16, pages 222 - 229 | - JANK, T.; GIESEMANN, T.; AKTORIES, K., GLYCOBIOLOGY, (2007), vol. 17, pages 15R - 22R | - JESPERS, L.; SCHON, O.; FAMM, K.; WINTER, G., NAT. BIOTECHNOL., (2004), vol. 22, pages 1161 - 1165 | - JOHAL, S.S.; LAMBERT, C.P.; HAMMOND, J.; JAMES, P.D.; BORRIELLO, S.P.; MAHIDA, Y.R., J. CLIN. PATHOL., (2004), vol. 57, pages 973 - 979 | - JOHNSON, S., J. INFECT., (2009), vol. 58, pages 403 - 410 | - JUANG, P.; SKLEDAR, S.J.; ZGHEIB, N.K.; PATERSON, D.L.; VERGIS, E.N.; SHANNON, W.D.; ANSANI, N.T.; BRANCH, R.A., AM. J. INFECT. CONTROL, (2007), vol. 35, pages 131 - 137 | - KABAT, E.A.; WU, T.T., J. IMMUNOL., (1991), vol. 147, pages 1709 - 19 | - KATCHAR, K.; TAYLOR, C.P.; TUMMALA, S.; CHEN, X.; SHEIKH, J.; KELLY, C.P., CLIN. GASTROENTEROL. HEPATOL., (2007), vol. 5, pages 707 - 713 | - KEEL, M.K.; SONGER, J.G., VET. PATHOL., (2007), vol. 44, pages 814 - 822 | - KELLY, C.P.; CHETHAM, S.; KEATES, S.; BOSTWICK, E.F.; ROUSH, A.M.; CASTAGLIUOLO, I.; LAMONT J.T.; POTHOULAKIS, C, ANTIMICROB. AGENTS CHEMOTHER., (1997), vol. 41, pages 236 - 241 | - KELLY, C.P.; POTHOULAKIS, C.; LAMOUNT, J.T., N. ENGL. J. MED., (1994), vol. 330, pages 257 - 262 | - KELLY, C.P.; POTHOULAKIS, C.; ORELLANA, J.; LAMONT, J.T., GASTROENTEROLOGY, (1992), vol. 102, pages 35 - 40 | - NAT. REV. DRUG DISCOV., (2009), vol. 8, page 442 | - KELLY, C.P.; POTHOULAKIS, C.; VAVVA, F.; CASTAGLIUOLO, I.; BOSTWICK, E.F.; O'KEANE, J.C.; KEATES, S.; LAMONT, J.T., ANTIMICROB. AGENTS CHEMOTHER., (1996), vol. 40, pages 373 - 379 | - KINK, J.A.; WILLIAMS, J.A., INFECT. IMMUN., (1998), vol. 66, pages 2018 - 2025 | - KYNE, L.; HAMEL, M.B.; POLAVARAM, R.; KELLY, C.P, CLIN. INFECT. DIS., (2002), vol. 34, pages 346 - 353 | - KYNE, L.; WARNY, M.; QAMAR, A.; KELLY, C.P., N. ENGL. J. MED., (2000), vol. 340, pages 390 - 397 | - KYNE, L.; WARNY, M.; QAMAR, A.; KELLY, C.P., LANCET, (2001), vol. 357, pages 189 - 193 | - LEFFLER, D.A.; LAMONT, J.T., GASTROENTEROLOGY, (2009), vol. 136, pages 1899 - 1912 | - LEFRANC, M.-P. ET AL., DEV. COMP. IMMUNOL., (2003), vol. 27, pages 55 - 77 | - LEUNG, D.Y.; KELLY, C.P.; BOGUNIEWICZ, M.; POTHOULAKIS, C.; LAMONT, J.T.; FLORES, A., J. PEDIATR., (1991), vol. 118, pages 633 - 637 | - LIU, J.L.; ANDERSON, G.P.; GOLDMAN, E.R., BMC BIOTECHNOL., (2007), vol. 7, pages 78 - 88 | - LOWY, I.; MOLRINE, D.C.; LEAV, B.A.; BLAIR, B.M.; BAXTER, R.; GERDING, D.N.; NICHOL, G.; THOMAS, W.D. JR.; LENEY, M.; SLOAN, S., N. ENGL. J. MED., (2010), vol. 362, pages 197 - 205 | - LYERLY, D.M.; BOSTWICK, E.F.; BINION, S.B.; WILKINS, T.D., INFECT. IMMUN., (1991), vol. 59, pages 2215 - 2218 | - LYERLY, D.M.; PHELPS, C.J.; TOTH, J.; WILKINS, J.D., INFECT. IMMUN., (1986), vol. 54, pages 70 - 76 | - LYRAS, D.; O'CONNOR, J.R.; HOWARTH, P.M.; SAMBOL, S.P.; CARTER, G.P.; PHUMOONNA, T.; POON, R.; ADAMS, V.; VEDANTAM, G.; JOHNSON, S, NATURE, (2009), vol. 458, pages 1176 - 1179 | - MCPHERSON, S.; REES, C.J.; ELLIS, R.; SOO, S.; PANTER, S.J., DIS. COLON RECTUM, (2006), vol. 49, pages 640 - 645 | - MERRITT, E.A.; HOL, W.G., CURR. OPIN. STRUCT. BIOL., (1995), vol. 5, pages 165 - 171 | - MUSHER, D.M.; MANHAS, A.; JAIN, P.; NUILA, F.; WAQAR, A.; LOGAN, N.; MARINO, B.; GRAVISS, E.A., J. CLIN. MICROBIOL., (2007), vol. 45, pages 2737 - 2739 | - NIELSEN, U.B.; ADAMS, G.P.; WEINER, L.M.; MARKS, J.D., CANCER RES., (2000), vol. 60, pages 6434 - 6440 | - NUTTALL, S.D.; KRISHNAN, U.V.; DOUGHTY, L.; PEARSON, K.; RYAN, M.T.; HOOGENRAAD, N.J.; HATTARKI, M.; CARMICHAEL, J.A.; IRVING, R.A, EUR. J. BIOCHEM., (2003), vol. 270, pages 3543 - 3554 | - O'CONNOR, J.R.; JOHNSON, S.; GERDING, D.N., GASTROENTEROLOGY, (2009), vol. 136, pages 1913 - 1924 | - OCHSNER, U.A.; BELL, S.J.; O'LEARY, A.L.; HOANG, T.; STONE, K.C.; YOUNG, C.L.; CRITCHLEY, I.A.; JANJIC, N., J. ANTIMICROB. CHEMOTHER., (2009), vol. 63, pages 964 - 971 | - PACE, C. N.; VAJDOS, F.; FEE, L.; GRIMSLEY, G.; GRAY, T., PROTEIN SCI., (1995), vol. 4, pages 2411 - 2423 | - PEPIN, J.; VALIQUETTE, L.; COSSETTE, B., CMAJ, (2005), vol. 173, pages 1037 - 1042 | - PLANCHE, T.; AGHAIZU, A.; HOLLIMAN, R.; RILEY, P.; POLONIECKI, J.; BREATHNACH, A.; KRISHNA, S., LANCET INFECT. DIS., (2008), vol. 8, pages 777 - 784 | - RIDGWAY, J.B.; PRESTA, L.G.; CARTER, P., PROTEIN ENG., (1996), vol. 9, pages 617 - 621 | - RUPNIK, M.; WILCOX, M.H.; GERDING, D.N., NAT. REV. MICROBIOL., (2009), vol. 7, pages 526 - 536 | - RUSSMANN, H.; PANTHEL, K.; BADER, R.C.; SCHMITT, C.; SCHAUMANN, R., EUR. J. CLIN. MICROBIOL. INFECT. DIS., (2007), vol. 26, pages 115 - 119 | - SAERENS, D.; CONRATH, K.; GOVAERT, J.; MUYLDERMANS, S., J. MOL. BIOL., (2008), vol. 377, pages 478 - 488 | - SALCEDO, J.; KEATES, S.; POTHOULAKIS, C.; WARNY, M.; CASTAGLIUOLO, I.; LAMONT, J.T.; KELLY, C.P., GUT, (1997), vol. 41, pages 366 - 370 | - SALNIKOVA, M.S.; JOSHI, S.B.; RYTTING, J.H.; WARNY, M.; MIDDAUGH, C.R., J. PHARM. SCI., (2008), vol. 97, pages 3735 - 3752 | - SLOAN, L.M.; DURESKO, B.J.; GUSTAFSON, D.R.; ROSENBLATT, J.E., J. CLIN. MICROBIOL., (2008), vol. 46, pages 1996 - 2001 | - SONGER, J.G., ANIM. HEALTH RES., (2004), vol. 5, pages 321 - 326 | - STEWART, C.S.; MACKENZIE, C.R.; HALL, J.C., TOXICON, (2007), vol. 49, pages 699 - 709 | - TANHA, J.; MURUGANANDAM, A.; STANIMIROVIC, D., METHODS MOL. MED., (2003), vol. 89, pages 435 - 449 | - THOMPSON, J.D.; HIGGINS, D.G.; GIBSON, T.J., NUCLEIC ACIDS RES., (1994), vol. 22, pages 4673 - 4680 | - TJELLSTROM, B.; STENHAMMAR, L.; ERIKSSON, S.; MAGNUSSON, K.E., LANCET, (1993), vol. 341, pages 701 - 702 | - TO, R.; HIRAMA, T.; ARBABI-GHAHROUDI, M.; MACKENZIE, R.; WANG, P.; XU, P.; NI, F.; TANHA, J., J. BIOL. CHEM., (2005), vol. 280, pages 41395 - 41403 | - TURGEON, D.K.; NOVICKI, T.J.; QUICK, J.; CARLSON, L.; MILLER, P.; ULNESS, B.; CENT, A.; ASHLEY, R.; LARSON, A.; COYLE, M., J. CLIN. MICROBIOL., (2003), vol. 41, pages 667 - 670 | - VISCIDI, R.; LAUGHON, B.E.; YOLKEN, R.; BO-LINN, P.; MOENCH, T.; RYEDER, R.W.; BARTLETT, J.G., J. INFECT. DIS., (1983), vol. 148, pages 93 - 100 | - VU, K.B.; GHAHROUDI, M.A.; WYNS, L.; MUYLDERMANS, S., MOL. IMMUNOL., (1997), vol. 34, pages 1121 - 1131 | - WARNY, M.; FATIMI, A.; BOSTWICK, E.F.; LAINE, D.C.; LABEL, F.; LAMONT, J.T.; POTHOULAKIS, C.; KELLY, C.P., GUT, (1999), vol. 44, pages 212 - 217 | - WARNY, M.; PEPIN, J.; FANG, A.; KILLGORE, G.; THOMPSON, A.; BRAZIER, J.; FROST, E.; MCDONALD, L.C., LANCET, (2005), vol. 366, pages 1079 - 1084 | - WARNY, M.; VAERMAN, J.P.; AVESANI, V.; DELMEE, M., INFECT. IMMUN., (1994), vol. 62, pages 384 - 389 | - WESOLOWSKI, J.; ALZOGARAY, V.; REYELT, J.; UNGER, M.; JUAREZ, K.; URRUTIA, M.; CAUERHFF, A.; DANGUAH, W.; RISSIEK, B.; SCHEUPLEIN,, MED. MICROBIOL. IMMUNOL., (2009), vol. 198, pages 157 - 174 | - WILCOX, N.H., J. ANTIMICROB. CHEMOTHER., (2004), vol. 53, pages 882 - 884 | - WILKINS, T.D.; LYERLY, D.M., J. CLIN. MICROBIOL., (2003), vol. 41, pages 531 - 534 | - ZHANG, J.; LI, Q.; NGUYEN, T.-D.; TREMBLAY, T.-L.; STONE, E.; TO, R.; KELLY, J.; MACKENZIE, C.R., J. MOL. BIOL., (2004), vol. 341, pages 161 - 169 | - ZHANG, J.; TANHA, J.; HIRAMA, T.; KHIEW, N.H.; TO, R.; TONG-SEVINC, H.; STONE, E.; BRISSON, J.R.; MACKENZIE, C.R., J. MOL. BIOL., (2004), vol. 335, pages 49 - 56 |